BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $672,513 | +54.7% | 25,503 | +0.9% | 0.00% | +100.0% |
Q2 2023 | $434,816 | +14.2% | 25,280 | +10.1% | 0.00% | 0.0% |
Q1 2023 | $380,610 | +92.2% | 22,956 | -11.7% | 0.00% | 0.0% |
Q4 2022 | $198,013 | -17.1% | 25,986 | +8.3% | 0.00% | 0.0% |
Q3 2022 | $239,000 | +5.3% | 24,001 | -4.1% | 0.00% | 0.0% |
Q2 2022 | $227,000 | -40.4% | 25,020 | -33.5% | 0.00% | 0.0% |
Q1 2022 | $381,000 | -51.0% | 37,637 | -19.2% | 0.00% | -50.0% |
Q4 2021 | $778,000 | -65.7% | 46,605 | -3.7% | 0.00% | -66.7% |
Q3 2021 | $2,267,000 | -32.1% | 48,371 | -11.6% | 0.01% | -40.0% |
Q2 2021 | $3,337,000 | +18.0% | 54,744 | +19.2% | 0.01% | +11.1% |
Q1 2021 | $2,829,000 | +13.5% | 45,922 | +31.0% | 0.01% | 0.0% |
Q4 2020 | $2,492,000 | +131.8% | 35,050 | +22.4% | 0.01% | +80.0% |
Q3 2020 | $1,075,000 | +12.6% | 28,646 | -2.2% | 0.01% | 0.0% |
Q2 2020 | $955,000 | +53.8% | 29,292 | +36.9% | 0.01% | +25.0% |
Q1 2020 | $621,000 | -40.5% | 21,398 | -28.2% | 0.00% | -20.0% |
Q4 2019 | $1,044,000 | – | 29,786 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |